GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (BSP:MDTC34) » Definitions » Cyclically Adjusted PS Ratio

Medtronic (BSP:MDTC34) Cyclically Adjusted PS Ratio : 3.33 (As of Apr. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medtronic Cyclically Adjusted PS Ratio?

As of today (2024-04-27), Medtronic's current share price is R$202.54. Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 was R$60.89. Medtronic's Cyclically Adjusted PS Ratio for today is 3.33.

The historical rank and industry rank for Medtronic's Cyclically Adjusted PS Ratio or its related term are showing as below:

BSP:MDTC34' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.8   Med: 5.01   Max: 6.71
Current: 3.19

During the past years, Medtronic's highest Cyclically Adjusted PS Ratio was 6.71. The lowest was 2.80. And the median was 5.01.

BSP:MDTC34's Cyclically Adjusted PS Ratio is ranked worse than
60.86% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs BSP:MDTC34: 3.19

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medtronic's adjusted revenue per share data for the three months ended in Jan. 2024 was R$14.937. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is R$60.89 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medtronic Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Medtronic's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Cyclically Adjusted PS Ratio Chart

Medtronic Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.78 5.08 6.51 4.69 3.74

Medtronic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.57 3.74 3.54 2.81 3.50

Competitive Comparison of Medtronic's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Medtronic's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medtronic's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medtronic's Cyclically Adjusted PS Ratio falls into.



Medtronic Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medtronic's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=202.54/60.89
=3.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medtronic's Cyclically Adjusted Revenue per Share for the quarter that ended in Jan. 2024 is calculated as:

For example, Medtronic's adjusted Revenue per Share data for the three months ended in Jan. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=14.937/120.1096*120.1096
=14.937

Current CPI (Jan. 2024) = 120.1096.

Medtronic Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201404 5.033 100.673 6.005
201407 4.727 100.573 5.645
201410 5.385 100.274 6.450
201501 5.712 98.779 6.945
201504 7.712 99.975 9.265
201507 8.175 100.374 9.782
201510 9.571 100.075 11.487
201601 9.887 98.879 12.010
201604 9.521 99.875 11.450
201607 8.347 100.872 9.939
201610 8.401 99.776 10.113
201701 8.399 99.178 10.172
201704 8.993 100.773 10.719
201707 8.594 100.673 10.253
201710 8.239 100.374 9.859
201801 8.739 99.377 10.562
201804 10.161 100.374 12.159
201807 10.335 101.470 12.233
201810 10.338 101.271 12.261
201901 10.419 100.075 12.505
201904 11.746 102.068 13.822
201907 10.471 101.969 12.334
201910 11.640 101.969 13.711
202001 11.852 101.371 14.043
202004 11.813 101.969 13.915
202007 12.709 101.570 15.029
202010 15.907 100.474 19.016
202101 15.387 101.171 18.267
202104 16.789 103.065 19.566
202107 15.195 103.763 17.589
202110 16.043 105.557 18.255
202201 15.896 106.255 17.969
202204 14.309 110.242 15.590
202207 14.825 113.232 15.725
202210 14.954 115.226 15.588
202301 15.060 114.528 15.794
202304 16.097 118.216 16.355
202307 13.860 119.811 13.895
202310 15.154 121.106 15.029
202401 14.937 120.110 14.937

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medtronic  (BSP:MDTC34) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medtronic Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Medtronic's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medtronic (BSP:MDTC34) Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Medtronic (BSP:MDTC34) Headlines

No Headlines